Lifespan Portfolio Company Rejuvenate Bio Closes $6 Million Financing and R&D Collaboration with Merck Animal Health
Milestone financing and R&D collaboration advances gene therapy programs targeting chronic and age-related diseases in companion animals. NORWALK, Conn., June 11, 2026 /PRNewswire/ -- Lifespan Vision Ventures (LVV), an investment firm focused on...
The Real Bottleneck in the Age of AI Agents Isn't the Model -- It's the Data
Singdata Closes Series B at over USD $100M, Launches in Hong Kong with a Bet on "AI-Native Data Infrastructure" — Aligned with the HKSAR Government's HKD 3 Billion "AI+" Strategy HONG KONG, June 9, 2026 /PRNewswire/ -- Enterprises worldwide are...
Digital Edge Successfully Closes First US$575 Million HoldCo Loan to Accelerate Growth Across Key Asia-Pacific Markets
SINGAPORE, May 22, 2026 /PRNewswire/ -- Digital Edge today announced the successful closing of its inaugural US$575 million holding company ("HoldCo") financing, marking a significant milestone in the company's continued evolution as one of...
Illuminate Financial Closes $135m Early Growth Fund to Back the Next Generation of AI & Fintech for Financial Services
LONDON, April 29, 2026 /PRNewswire/ -- Illuminate Financial has closed its fourth fund at $135 million, bringing together eight of the world's leading financial institutions to back Enterprise AI and Fintech companies building the infrastructure of...
NOVI Health's Hybrid Care Model Closes Gap Between Clinical Trials and Real-World GLP-1 Outcomes
An estimated ~14.7% weight loss at 18 months was achieved in one of the first studies evaluating integrated GLP-1 therapies and digital coaching in a multi-ethnic Asian population (n=708). This matched gold-standard clinical trial results, with...
Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies
SHANGHAI, April 10, 2026 /PRNewswire/ -- Oricell Therapeutics Holdings Limited ("Oricell"), a global clinical-stage biotechnology company pioneering innovative cancer immunotherapies, today announced the cumulative closing of a pre-IPO financing...
NSSK Closes Series IV Funds at JPY 250 Billion Hardcap, More Than 2x Oversubscribed
Fund substantially allocated within four months of launch; Thrive Alternatives served as exclusive advisor SINGAPORE, April 1, 2026 /PRNewswire/ -- Nippon Sangyo Suishin Kiko (NSSK), a leading Japan-focused private equity firm, today announced the...
ACOH 2026 Early Bird Rate Ends 30 April; Abstract Submission Closes 1 April
KUCHING, Malaysia, March 19, 2026 /PRNewswire/ -- Asia's leading platform on workplace health and safety, the 24th Asian Congress on Occupational Health (ACOH) 2026, is calling on researchers, practitioners, and industry professionals to secure...
Talino Closes $7.5M Series A to Launch a Global Fintech Foundry and Modernize Cross-border Infrastructure
MANILA, Philippines and LOS ANGELES, March 19, 2026 /PRNewswire/ -- Talino, the award-winning fintech foundry, today announced the successful closing of its $7.5 million Series A funding round. The round, which was led by Chemonics International, a...
Kinterra Capital Closes Oversubscribed US$950 Million Fund II Following Strong Investor Demand
TORONTO, Feb. 18, 2026 /PRNewswire/ -- Kinterra Capital Corp. ("Kinterra" or the "Firm"), a leading private equity firm investing in critical materials and the associated infrastructure essential to the modern economy, today announced the successful...